Good evening :)
Place Order
Add to Watchlist

Kerala Ayurveda Ltd

KERALAYUR

Kerala Ayurveda Ltd

KERALAYUR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹485 cr, stock is ranked 1,896
High RiskStock is 3.32x as volatile as Nifty
403.550.16% (+0.65)
403.550.16% (+0.65)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹485 cr, stock is ranked 1,896
High RiskStock is 3.32x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹485 cr, stock is ranked 1,896
High RiskStock is 3.32x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
189.5513.81
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.236.640.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Kerala Ayurveda Limited is an ayurveda company engaged in providing ayurvedic services and products. The Company is engaged in providing ayurvedic services and products.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 11.24%, vs industry avg of 9.04%

Constant Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.03%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue46.0250.5559.1363.6476.7962.1881.4993.70108.38112.97
Raw Materialssubtract9.3211.4211.5614.0615.3213.3017.4719.9725.30101.71
Power & Fuel Costsubtract0.550.690.731.141.981.222.092.232.35
Employee Costsubtract14.2116.1417.7820.9224.6322.0022.3128.1234.27
Selling & Administrative Expensessubtract9.919.2114.0415.4320.2714.0622.9128.4631.79
Operating & Other expensessubtract4.395.716.695.437.2110.666.059.187.38
Depreciation/Amortizationsubtract1.991.771.830.981.141.281.201.111.343.03
Interest & Other Itemssubtract1.541.432.342.571.706.416.675.194.663.48
Taxes & Other Itemssubtract1.411.121.360.660.64-1.890.440.342.802.19
EPS2.562.902.652.323.69-4.602.23-0.85-1.342.13
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Kerala Ayurveda Ltd-321.3613.81
Sun Pharmaceutical Industries Ltd45.626.510.74%
Mankind Pharma Ltd62.8312.55
Cipla Ltd28.944.450.88%

Price Comparison

Compare KERALAYUR with any stock or ETF
Compare KERALAYUR with any stock or ETF
KERALAYUR
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding58.58%0.02%0.01%0.00%41.38%

Jan 2024

Mar 2024

Jun 2024

Sep 2024

Shareholding History

SepDec '23JanMarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

KERALAYUR has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Corporate
Kerala Ayurveda EGM scheduled

Kerala Ayurveda announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 3 January 2025.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Kerala Ayurveda postpones board meeting

Kerala Ayurveda has postponed the meeting of the Board of Directors which was scheduled to be held on 9 December 2024. The meeting will now be held on a later date.Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Kerala Ayurveda schedules board meeting

Kerala Ayurveda will hold a meeting of the Board of Directors of the Company on 9 December 2024Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Kerala Ayurveda reports consolidated net profit of Rs 3.41 crore in the September 2024 quarter

Net profit of Kerala Ayurveda reported to Rs 3.41 crore in the quarter ended September 2024 as against net loss of Rs 0.13 crore during the previous quarter ended September 2023. Sales rose 21.49% to Rs 30.41 crore in the quarter ended September 2024 as against Rs 25.03 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales30.4125.03 21 OPM %18.182.16 - PBDT5.450.13 4092 PBT3.48-0.19 LP NP3.41-0.13 LP Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Kerala Ayurveda announces board meeting date

Kerala Ayurveda will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Kerala Ayurveda reports consolidated net profit of Rs 0.32 crore in the June 2024 quarter

Net profit of Kerala Ayurveda reported to Rs 0.32 crore in the quarter ended June 2024 as against net loss of Rs 0.36 crore during the previous quarter ended June 2023. Sales rose 15.52% to Rs 27.47 crore in the quarter ended June 2024 as against Rs 23.78 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales27.4723.78 16 OPM %2.956.43 - PBDT0.560.18 211 PBT0.21-0.15 LP NP0.32-0.36 LP Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Kerala Ayurveda to table results

Kerala Ayurveda will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live